Relmada Therapeutics, Inc. (RLMD)
4.355
-0.48
(-9.83%)
USD |
NASDAQ |
Jan 02, 16:00
4.355
0.00 (0.00%)
After-Hours: 16:06
Relmada Therapeutics Research and Development Expense (TTM): 29.81M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Amicus Therapeutics, Inc. | 142.29M |
| Invivyd, Inc. | 46.17M |
| Arcellx, Inc. | 168.16M |
| Puma Biotechnology, Inc. | 60.40M |
| Sensus Healthcare, Inc. | 7.457M |